Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Maxwell Plus logo — Empowering clinicians, researchers, and companies with advan...

Maxwell Plus

Empowering clinicians, researchers, and companies with advanced AI tools for swift and accurate clinical diagnostics, starting with prostate cancer testing.

Founded 2016 Non Equity Assistance Total: $4.56M AI, Health Care

General Information

Company Name Maxwell Plus
Founded Year 2016
Industries AI, Health Care
Funding Stage Non Equity Assistance
Social

BounceWatch is an independent company data service, not affiliated with Maxwell Plus. To contact Maxwell Plus, visit maxwellplus.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Maxwell Plus compare?

A PDF of Maxwell Plus and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Maxwell Plus soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Maxwell Plus

Maxwell Plus, founded in 2016, is a pioneering player in the intersection of AI and Health Care. The company's slogan "Empowering clinicians, researchers, and companies with advanced AI tools for swift and accurate clinical diagnostics, starting with prostate cancer testing" encapsulates its mission. Maxwell Plus offers a platform that empowers clinicians, researchers, and companies with advanced tools founded on medical imaging, pathology, and various data, expediting the creation and implementation of clinical diagnostics. Their initial diagnostic model focuses on prostate cancer. In March 2022, Maxwell Plus received Non Equity Assistance investment from the NHS Innovation Accelerator, highlighting the company's potential and the confidence of investors in its innovative approach to clinical diagnostics. This is a strong validation of Maxwell Plus's value proposition and indicates the potential for impactful advancements in the field of AI-powered clinical diagnostics. Maxwell Plus's innovative approach and recent investment from the NHS Innovation Accelerator position the company as a significant player in the AI-driven health care sector. This strategic investment will likely bolster Maxwell Plus's continued development and deployment of advanced AI tools for clinical diagnostics, signaling potential for further growth and impact in the health care industry.

Business keywords: AI platform, clinical diagnostics, medical imaging, pathology, prostate cancer testing, research tools, medical research, diagnostic model, data-driven solutions

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Non Equity Assistance Undisclosed 1
NHS Innovation Accelerator
NHS Innovation Accelerator
31 Mar 2022
Grant $1.10M 1
Cooperative Research Centre Projects
21 Sep 2018
Seed Round $3.40M 1
Main Sequence Ventures
Main Sequence Ventures
30 Oct 2017
Seed Round Undisclosed 1
RCL Accelerator
RCL Accelerator
01 Apr 2017
Pre Seed Round $60.00K 3
muru-D Transition Level Investments RCL Accelerator
muru-D, Transition Level Investments +1
22 Sep 2016

Maxwell Plus Alternatives & Competitors

View All Alternatives
Maxwell Plus vs
Aidence
Aidence The Netherlands

AI-powered clinical applications for the lung cancer pathway

Acquired
13 employees
AI, Health Care
Maxwell Plus vs
Neurabot Lab
Neurabot Lab Indonesia

Neurabot Lab is digital laboratory 4.0 platform and fighting cancer by AI technology in computationa...

Grant
10 employees
AI, Analytics
Maxwell Plus vs
Baixinghua AI
Baixinghua AI

Innovation through AI-driven insights for advanced medical research and clinical data integration.

Angel
11-50 employees
AI, Health Care
View all alternatives

FAQ About Maxwell Plus

Empowering clinicians, researchers, and companies with advanced AI tools for swift and accurate clinical diagnostics, starting with prostate cancer testing.
Maxwell Plus was founded in 2016.
Maxwell Plus operates in AI and Health Care. Its work centres on AI platform, clinical diagnostics, medical imaging and pathology.
Maxwell Plus has completed 5 funding rounds, raising a total of $4.56M. The latest funding stage is Non Equity Assistance.
Top alternatives and competitors to Maxwell Plus include Aidence, Neurabot Lab, Baixinghua AI, Aiosyn, AEQUIP S.r.l.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Maxwell Plus and Aidence are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Maxwell Plus, https://bouncewatch.com/company/maxwell-plus, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes